Twelve novel analogs of STAT3 inhibitor BP-1-102 were designed and synthesised with the aim to modify hydrophobic fragments of the molecules that are important for interaction with the STAT3 SH2 domain. The cytotoxic activity of the reference and novel compounds was evaluated using several human and two mouse cancer cell lines. BP-1-102 and its two analogs emerged as effective cytotoxic agents and were further tested in additional six human and two murine cancer cell lines, in all of which they manifested the cytotoxic effect in a micromolar range. Reference compound S3I-201.1066 was found ineffective in all tested cell lines, in contrast to formerly published data. The ability of selected BP-1-102 analogs to induce apoptosis and inhibition of STAT3 receptor-mediated phosphorylation was confirmed. The structure-activity relationship confirmed a demand for two hydrophobic substituents, i.e. the pentafluorophenyl moiety and another spatially bulky moiety, for effective cytotoxic activity and STAT3 inhibition.

Department of Chemistry Faculty of Science University of Hradec Kralove Hradec Kralove Czech Republic

Department of Genome Integrity Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czech Republic

Genome Integrity Unit Danish Cancer Society Research Center Copenhagen Denmark

Laboratory of Immunological and Tumour Models Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Tsurumi A, Zhao C, Li WX.. Canonical and non-canonical JAK/STAT transcriptional targets may be involved in distinct and overlapping cellular processes. BMC Genomics 2017;18:718. PubMed PMC

Darnell JE Jr. STATs and gene regulation. Science 1997;277:1630–5. PubMed

Bromberg J, Darnell JE Jr.. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000;19:2468–73. PubMed

Yu H, Jove R.. The STATs of cancer—new molecular targets come of age. Nat Rev Cancer 2004;4:97–105. PubMed

Bromberg JF, Wrzeszczynska MH, Devgan G Jr, et al. . Stat3 as an oncogene. Cell 1999;98:295–303. PubMed

Grandis JR, Drenning SD, Chakraborty A, et al. . Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J Clin Invest 1998;102:1385–92. PubMed PMC

Catlett-Falcone R, Landowski TH, Oshiro MM, et al. . Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999;10:105–15. PubMed

Hanahan D, Weinberg RA.. Hallmarks of cancer: the next generation. Cell 2011;144:646–74. PubMed

Verhoeven Y, Tilborghs S, Jacobs J, et al. . The potential and controversy of targeting STAT family members in cancer. Semin Cancer Biol 2019;60:41–56. PubMed

Bromberg JF. Activation of STAT proteins and growth control. Bioessays 2001;23:161–9. PubMed

Abou-Ghazal M, Yang DS, Qiao W, et al. . The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. Clin Cancer Res 2008;14:8228–35. PubMed PMC

Lin GS, Yang LJ, Wang XF, et al. . STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma. Med Oncol 2014;31:924. PubMed

Furtek SL, Backos DS, Matheson CJ, Reigan P.. Strategies and approaches of targeting STAT3 for cancer treatment. ACS Chem Biol 2016;11:308–18. PubMed

Deng J, Grande F, Neamati N.. Small molecule inhibitors of Stat3 signaling pathway. Curr Cancer Drug Targets 2007;7:91–107. PubMed

Turkson J, Ryan D, Kim JS, et al. . Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem 2001;276:45443–55. PubMed

Matsuno K, Masuda Y, Uehara Y, et al. . Identification of a new series of STAT3 inhibitors by virtual screening. ACS Med Chem Lett 2010;1:371–5. PubMed PMC

Siddiquee K, Zhang S, Guida WC, et al. . Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci U S A 2007;104:7391–6. PubMed PMC

Schust J, Sperl B, Hollis A, et al. . Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 2006;13:1235–42. PubMed

Turkson J, Zhang S, Mora LB, et al. . A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells. J Biol Chem 2005;280:32979–88. PubMed

Ren X, Duan L, He Q, et al. . Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway. ACS Med Chem Lett 2010;1:454–9. PubMed PMC

Horiguchi A, Asano T, Kuroda K, et al. . STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma. Br J Cancer 2010;102:1592–9. PubMed PMC

Iwamaru A, Szymanski S, Iwado E, et al. . A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 2007;26:2435–44. PubMed

Huang Q, Zhong Y, Dong H, et al. . Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: where are we and where should we go? Eur J Med Chem 2020;187:111922. PubMed

Zhang X, Yue P, Page BD, et al. . Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proc Natl Acad Sci USA 2012;109:9623–8. PubMed PMC

Wager TT, Hou X, Verhoest PR, Villalobos A.. Central nervous system multiparameter optimization desirability: application in drug discovery. ACS Chem Neurosci 2016;7:767–75. PubMed

Page BD, Fletcher S, Yue P, et al. . Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain. Bioorg Med Chem Lett 2011;21:5605–9. PubMed PMC

Brown JW, Byron DJ, Southcott M, et al. . Properties of the liquid crystals formed by certain azomethines derived from 4-cycloalkylanilines and from 4-cycloalkylbenzaldehydes. Mol Cryst Liq Cryst Incorp Nonlin Opt 1988;159:37–52.

Haftchenary S, Luchman HA, Jouk AO, et al. . Potent targeting of the STAT3 protein in brain cancer stem cells: a promising route for treating glioblastoma. ACS Med Chem Lett 2013;4:1102–7. PubMed PMC

Yadav MR, Grande F, Chouhan BS, et al. . Cytotoxic potential of novel 6,7-dimethoxyquinazolines. Eur J Med Chem 2012;48:231–43. PubMed

Grande F, Yamada R, Cao X, et al. . Synthesis and biological evaluation of novel hydrazide based cytotoxic agents. Expert Opin Investig Drugs 2009;18:555–68. PubMed

Zhang X, Yue P, Fletcher S, et al. . A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes. Biochem Pharmacol 2010;79:1398–409. PubMed PMC

Chen H, Yang Z, Ding C, et al. . Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy. Eur J Med Chem 2013;62:498–507. PubMed PMC

Zhang W, Ma T, Li S, et al. . Antagonizing STAT3 activation with benzo[b]thiophene 1, 1-dioxide based small molecules. Eur J Med Chem 2017;125:538–50. PubMed

Anoopkumar-Dukie S, Carey JB, Conere T, et al. . Resazurin assay of radiation response in cultured cells. Br J Radiol 2005;78:945–7. PubMed

Lin KY, Guarnieri FG, Staveley-O'Carroll KF, et al. . Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996;56:21–6. PubMed

Foster BA, Gingrich JR, Kwon ED, et al. . Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 1997;57:3325–30. PubMed

Mikyskova R, Stepanek I, Indrova M, et al. . Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy. Int J Oncol 2016;48:953–64. PubMed PMC

Pechackova S, Burdova K, Benada J, et al. . Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3. Oncotarget 2016;7:14458–75. PubMed PMC

Feoktistova M, Geserick P, Leverkus M.. Crystal violet assay for determining viability of cultured cells. Cold Spring Harb Protoc 2016;2016:pdb.prot087379. PubMed

Peroxiredoxin 6 protects irradiated cells from oxidative stress and shapes their senescence-associated cytokine landscape